Molly Harper - 03 Jun 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Molly Harper
Issuer symbol
CPRX
Transactions as of
03 Jun 2024
Net transactions value
-$86,949
Form type
4
Filing time
05 Jun 2024, 17:00:21 UTC
Previous filing
16 Feb 2024
Next filing
25 Nov 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common Stock, par value $0.001 per share Sale $86,949 -5,333 -100% $16.30 0 03 Jun 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold for personal reasons and not as a result of any disagreement with the Company. Ms. Harper remains a director of the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in a range between $16.26 and $16.34 per share.